Xospata

Astellas Xospata comes up short again in bid to expand leukemia use
Fierce Pharma
Thu, 03/9/23 - 09:13 pm
Astellas
Xospata
AML
clinical trials
Astellas maintains lead over Daiichi Sankyo with CHMP okay for Xospata
Pharmaforum
Sun, 09/22/19 - 11:02 pm
Astellas
AML
Xospata
Europe
Daiichi Sankyo
AACR: Astellas pads Xospata's AML lead with chemo-beating survival data
Fierce Pharma
Mon, 04/1/19 - 12:38 pm
Astellas
Xospata
acute myeloid leukemia
AML
AACR
FDA stamps fast OK on Astellas' pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals
Endpoints
Thu, 11/29/18 - 12:10 am
Astellas
FDA
AML
Xospata
gilteritinib